window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Movers & Shakers

  • Biologics & Biosimilars,Biotech,Movers & Shakers

    FairJourney Biologics appoints Werner Lanthaler as chief executive officer

    FairJourney Biologics has appointed Werner Lanthaler as chief executive officer [...]

    October 13, 2025
  • Artificial Intelligence,Biotech,Movers & Shakers,Research & Development,Technology and platforms

    Sapio Sciences appoints Rich Roda as chief financial officer

    Sapio Sciences has appointed Rich Roda as chief financial officer, [...]

    October 6, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Movers & Shakers,Technology and platforms

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    October 6, 2025
  • Digital Health,Global health,Market Access & Commercialization,Movers & Shakers,Patient Centricity,Pharmaceuticals and therapeutics,Technology and platforms

    HeliosX strengthens leadership team to drive global growth and brand innovation

    HeliosX has expanded its senior leadership team with the appointments [...]

    October 2, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Movers & Shakers,Pharmaceuticals and therapeutics,Technology and platforms

    DaltonTx raises £4 million seed financing to build AI-enabled drug discovery platform

    DaltonTx, a UK-based technology company, has exited stealth mode and [...]

    September 23, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development,Drug Development,Movers & Shakers,Pharmaceuticals and therapeutics

    Formation Bio expands leadership team with biotech and pharma veterans to accelerate AI-driven drug development

    Formation Bio, the AI-native pharmaceutical company advancing a new model [...]

    September 23, 2025
  • Global health,Movers & Shakers,Partnerships & Funding

    The Biotech Growth Trust appoints Dame Jenny Harries as non-executive director

    The Biotech Growth Trust has appointed Dame Jenny Harries as [...]

    September 23, 2025
  • Medical devices,Movers & Shakers,Pharmaceuticals and therapeutics,Technology and platforms

    Oral BioLife appoints Greg Ambra as CEO and strengthens leadership team

    Oral BioLife, a regenerative technology company developing non-invasive therapies to [...]

    September 23, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Movers & Shakers,Pharmaceuticals and therapeutics

    Chrysalis appoints Adam Bartley as chief operating officer

    Chrysalis, a provider of GMP cleanroom hosting and support services [...]

    September 23, 2025
  • Clinical Development,Drug Development,Movers & Shakers,Oncology,Pharmaceuticals and therapeutics

    Pheon therapeutics strengthens board with oncology R&D expert Dr Samuel Blackman

    Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

    September 23, 2025
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top